Cargando…

Comprehensive pharmacogenomic characterization of gastric cancer

BACKGROUND: Gastric cancer is among the most lethal human malignancies. Previous studies have identified molecular aberrations that constitute dynamic biological networks and genomic complexities of gastric tumors. However, the clinical translation of molecular-guided targeted therapy is hampered by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sa, Jason K., Hong, Jung Yong, Lee, In-Kyoung, Kim, Ju-sun, Sim, Moon-Hee, Kim, Ha Jung, An, Ji Yeong, Sohn, Tae Sung, Lee, Joon Ho, Bae, Jae Moon, Kim, Sung, Kim, Kyoung-Mee, Kim, Seung Tae, Park, Se Hoon, Park, Joon Oh, Lim, Ho Yeong, Kang, Won Ki, Her, Nam-Gu, Lee, Yeri, Cho, Hee Jin, Shin, Yong Jae, Kim, Misuk, Koo, Harim, Kim, Mirinae, Seo, Yun Jee, Kim, Ja Yeon, Choi, Min-Gew, Nam, Do-Hyun, Lee, Jeeyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029441/ https://www.ncbi.nlm.nih.gov/pubmed/32070411 http://dx.doi.org/10.1186/s13073-020-0717-8

Ejemplares similares

Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability
por: Cho, Junhun, et al.
Publicado: (2017)

Adjuvant Chemotherapy with or without Concurrent Radiotherapy for Patients with Stage IB Gastric Cancer: a Subgroup Analysis of the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Phase III Trial
por: Kim, Youjin, et al.
Publicado: (2018)

The Influence of Metastatic Lymph Node Ratio on the Treatment Outcomes in the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Trial: A Phase III Trial
por: Kim, Youjin, et al.
Publicado: (2016)

Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer()
por: Kim, Seung Tae, et al.
Publicado: (2015)

Deep Learning–Based Survival Analysis Identified Associations Between Molecular Subtype and Optimal Adjuvant Treatment of Patients With Gastric Cancer
por: Lee, Jeeyun, et al.
Publicado: (2018)

Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer
por: Yu, Jeong Il, et al.
Publicado: (2020)

Claudin 18.2 expression in various tumor types and its role as a potential target in advanced gastric cancer
por: Hong, Jung Yong, et al.
Publicado: (2020)

Plexiform Angiomyxoid Myofibroblastic Tumor of the Stomach: a Rare Case
por: Kim, Su Mi, et al.
Publicado: (2017)

Prognostic Value of Highly Expressed Type VII Collagen (COL7A1) in Patients With Gastric Cancer
por: Oh, Sung Eun, et al.
Publicado: (2021)

Clinical sequencing to assess tumor mutational burden as a useful biomarker to immunotherapy in various solid tumors
por: Kim, Hana, et al.
Publicado: (2021)

Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer
por: LIM, SUNG HEE, et al.
Publicado: (2023)

Protective Effects of Female Reproductive Factors on Lauren Intestinal-Type Gastric Adenocarcinoma
por: Kim, Su Mi, et al.
Publicado: (2018)

MerTK inhibition by RXDX-106 in MerTK activated gastric cancer cell lines
por: Kim, Jung Eun, et al.
Publicado: (2017)

Risk Factors and Tumor Recurrence in pT1N0M0 Gastric Cancer after Surgical Treatment
por: Choi, Hee Jun, et al.
Publicado: (2016)

Comparison of the 7th and the 8th AJCC Staging System for Non-metastatic D2-Resected Lymph Node–Positive Gastric Cancer Treated with Different Adjuvant Protocols
por: Yu, Jeong Il, et al.
Publicado: (2019)

Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers
por: Sa, Jason K., et al.
Publicado: (2019)

A comparison of short-term postoperative outcomes including nutritional status between gastrectomy with simultaneous cholecystectomy and gastrectomy only in patients with gastric cancer
por: Kim, You Na, et al.
Publicado: (2019)

First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients
por: Kim, Seung Tae, et al.
Publicado: (2020)

The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors
por: Kim, Hana, et al.
Publicado: (2021)

Impact of Radiotherapy on Kidney Function among Patients Who Received Adjuvant Treatment for Gastric Cancer: Logistic and Linear Regression Analyses
por: Park, Jun Su, et al.
Publicado: (2020)

Clinical Significance of Preoperative Hematological Parameters in Patients with D2-Resected, Node-Positive Stomach Cancer
por: Park, Jun Su, et al.
Publicado: (2022)

A Multi-cohort Study of the Prognostic Significance of Microsatellite Instability or Mismatch Repair Status after Recurrence of Resectable Gastric Cancer
por: An, Ji Yeong, et al.
Publicado: (2020)

Nanostring-Based Multigene Assay to Predict Recurrence for Gastric Cancer Patients after Surgery
por: Lee, Jeeyun, et al.
Publicado: (2014)

The Clinical Impact of c-MET Over-Expression in Advanced Biliary Tract Cancer (BTC)
por: Heo, Mi Hwa, et al.
Publicado: (2017)

RRAD expression in gastric and colorectal cancer with peritoneal carcinomatosis
por: Kim, Hee Kyung, et al.
Publicado: (2019)

MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer
por: Ko, Jihoon, et al.
Publicado: (2022)

Long-term effect of simplified dietary education on the nutritional status of patients after a gastrectomy
por: Ryu, Kyeong-Won, et al.
Publicado: (2021)

Should an Aberrant Left Hepatic Artery Arising from the Left Gastric Artery Be Preserved during Laparoscopic Gastrectomy for Early Gastric Cancer Treatment?
por: Kim, Jieun, et al.
Publicado: (2016)

Successful Robotic Gastrectomy Does Not Require Extensive Laparoscopic Experience
por: An, Ji Yeong, et al.
Publicado: (2018)

Detection of Fusion Genes Using a Targeted RNA Sequencing Panel in Gastrointestinal and Rare Cancers
por: Lee, Su Jin, et al.
Publicado: (2020)

High-Throughput Sequencing and Copy Number Variation Detection Using Formalin Fixed Embedded Tissue in Metastatic Gastric Cancer
por: Kim, Seokhwi, et al.
Publicado: (2014)

Direct analysis of aberrant glycosylation on haptoglobin in patients with gastric cancer
por: Kim, Jae-Han, et al.
Publicado: (2016)

A Risk Prediction Model Based on Lymph-Node Metastasis in Poorly Differentiated–Type Intramucosal Gastric Cancer
por: Pyo, Jeung Hui, et al.
Publicado: (2016)

Short-Term Outcomes of Intracorporeal Delta-Shaped Gastroduodenostomy Versus Extracorporeal Gastroduodenostomy after Laparoscopic Distal Gastrectomy for Gastric Cancer
por: Kim, You Na, et al.
Publicado: (2019)

A Novel Proteomics-Based Clinical Diagnostics Technology Identifies Heterogeneity in Activated Signaling Pathways in Gastric Cancers
por: Lee, Jeeyun, et al.
Publicado: (2013)

Correlating programmed death ligand 1 (PD-L1) expression, mismatch repair deficiency, and outcomes across tumor types: implications for immunotherapy
por: Kim, Seung Tae, et al.
Publicado: (2017)

Exome Sequencing Identifies Early Gastric Carcinoma as an Early Stage of Advanced Gastric Cancer
por: Kang, Guhyun, et al.
Publicado: (2013)

Antitumor Effect of AZD4547 in a Fibroblast Growth Factor Receptor 2–Amplified Gastric Cancer Patient–Derived Cell Model()
por: Jang, Jiryeon, et al.
Publicado: (2017)

Variation of Mechanical Characteristics of Polyurethane Foam: Effect of Test Method
por: Park, Ki-Beom, et al.
Publicado: (2019)

The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs
por: Kim, Seung Tae, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tee6ocooh08mhf32k5kd5261ta